Aptevo Therapeutics Inc. (APVO) shareholders
Close on Nov 17, 2026Market cap $830.71KP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Waqas Khatri Joint filing with Ayrton Capital LLC (10.00%), Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (10.00%) | 358,150 | 10.00% | 13G (passive) | Jun 30, 2025 |
| Mark Angelo Joint filing with YA II PN, Ltd. (9.99%), YA Global Investments II (U.S.), LP (9.99%) and 5 more | 357,842 | 9.99% | 13G (passive) | Jun 16, 2025 |
| Bigger Michael Joint filing with Bigger Capital Fund L P (9.95%), Bigger Capital Fund GP, LLC (9.95%) | 285,000 | 9.95% | 13G (passive) | Jun 18, 2025 |
| Bigger Capital Fund L P Joint filing with Bigger Capital Fund GP, LLC (6.20%), Bigger Michael (6.20%) | 200,000 | 6.20% | 13G (passive) | Apr 3, 2025 |
| Niowave, Inc. | 151,723 | 12.20% | 13G (passive) | May 25, 2026 |
| Heights Capital Management, Inc. Joint filing with CVI Investments, Inc. (6.30%) | 83,854 | 6.30% | 13G (passive) amendment | Jun 30, 2026 |
| CVI Investments, Inc. Joint filing with Heights Capital Management, Inc. (8.20%) | 83,854 | 8.20% | 13G (passive) amendment | Dec 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of APVO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Gsa Capital Partners Llp | 21,539 | 1.20% | $96.00K | +1,901 | 0.01% |
| Vanguard Capital Management LLC | 12,713 | 0.71% | $56.45K | – | 0.00% |
| Geode Capital Management, LLC | 10,821 | 0.60% | $48.04K | −2,516 | 0.00% |
| Vanguard Fiduciary Trust Co | 4,142 | 0.23% | $18.39K | – | 0.00% |
| UBS Group AG | 730 | 0.04% | $3.24K | −2,715 | 0.00% |
| Osaic Holdings, Inc. | 360 | 0.02% | $1.60K | – | 0.00% |
| SBI Securities Co., Ltd. | 109 | 0.01% | $484 | – | 0.00% |
| Barclays PLC | 31 | 0.00% | $138 | New | 0.00% |
| Danske Bank A/S | 1 | 0.00% | $4 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 9 | 0M | 2.8% | 1 / 1 | 2 / 0 | 0M | 0M |
| Q1 2026 | 9 | 0M | 3.0% | 4 / 2 | 1 / 5 | 0M | 0M |
| Q4 2025 | 11 | 0M | 1.1% | 11 / 0 | 0 / 0 | 0M | 0M |
| Q1 2017 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q4 2016 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2016 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
3 funds held APVO in Q2 2026, 55% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of APVO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 12,713 | 0.71% | $56.45K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 8,901 | 0.49% | $43.70K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 1,548 | 0.09% | $7.60K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jeffrey G. Lamothe | President and CEO, Director | 961 | 0.05% | Aug 10, 2026 |
| Marvin L. White | Executive Chair, Director | 1,667 | 0.09% | Aug 10, 2026 |
| Daphne Taylor | SVP, CFO | 638 | 0.04% | Aug 10, 2026 |
| Dirk Huebner | SVP, CMO | 638 | 0.04% | Aug 10, 2026 |
| SoYoung Kwon | SVP, GC, BD & Corp Affairs | 638 | 0.04% | Aug 10, 2026 |
| Mary Jo Janatpour | SVP, CSO | 0 | – | May 28, 2026 |
| Daniel Abdun-Nabi | Director | 400 | 0.02% | Aug 10, 2026 |
| Barbara Lopez Kunz | Director | 400 | 0.02% | Aug 10, 2026 |
| John Niederhuber | Director | 400 | 0.02% | Aug 10, 2026 |
| Grady Grant III | Director | 1,150 | 0.06% | Aug 10, 2026 |
| Zsolt Harsanyi | Director | 400 | 0.02% | Aug 10, 2026 |
| Niowave, Inc. | 10% owner | 98,522 | 5.47% | Jun 22, 2026 |
| Of America Na Bank | 10% owner | – | – | Oct 3, 2025 |
| Bofa Securities, Inc. | 10% owner | 27 | 0.00% | Oct 3, 2025 |
| Of America Corp /De/ Bank | 10% owner | – | – | Oct 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Barbara Lopez Kunz Director | Aug 6, 2026 | Option exercise | +400 | – | – | 400 |
| Zsolt Harsanyi Director | Aug 6, 2026 | Option exercise | +400 | – | – | 400 |
| Daniel Abdun-Nabi Director | Aug 6, 2026 | Option exercise | +400 | – | – | 400 |
| Dirk Huebner SVP, CMO | Aug 6, 2026 | Option exercise | +638 | – | – | 638 |
| Dirk Huebner SVP, CMO | Aug 6, 2026 | Tax withholding | −156 | $4.07 | $635 | 482 |
| Jeffrey G. Lamothe President and CEO, Director | Aug 6, 2026 | Option exercise | +961 | – | – | 961 |
| Grady Grant III Director | Aug 6, 2026 | Option exercise | +400 | – | – | 1,150 |
| John Niederhuber Director | Aug 6, 2026 | Option exercise | +400 | – | – | 400 |
| Marvin L. White Executive Chair, Director | Aug 6, 2026 | Option exercise | +1,666 | – | – | 1,667 |
| Marvin L. White Executive Chair, Director | Aug 6, 2026 | Tax withholding | −406 | $4.07 | $1.65K | 1,261 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Aug 6, 2026 | Option exercise | +638 | – | – | 638 |
| Daphne Taylor SVP, CFO | Aug 6, 2026 | Option exercise | +638 | – | – | 638 |
| Marvin L. White Executive Chair, Director | Jul 17, 2026 | Option exercise | +1 | – | – | 1 |
| Grady Grant III Director | Nov 10, 2025 | Buy | +13,513 | $1.49 | $20.13K | 13,514 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Jul 17, 2025 | Option exercise | +3 | – | – | 4 |
| John Niederhuber Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Daphne Taylor SVP, CFO | Jul 17, 2025 | Option exercise | +3 | – | – | 3 |
| Grady Grant III Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Marvin L. White President and CEO, Director | Jul 17, 2025 | Option exercise | +10 | – | – | 12 |
| Zsolt Harsanyi Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Barbara Lopez Kunz Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Jeffrey G. Lamothe EVP, COO | Jul 17, 2025 | Option exercise | +5 | – | – | 6 |
| Daniel Abdun-Nabi Director | Jul 17, 2025 | Option exercise | +1 | – | – | 1 |
| Daphne Taylor SVP, CFO | Mar 4, 2025 | Option exercise | +1 | – | – | 18 |
| Jeffrey G. Lamothe EVP, COO | Mar 3, 2025 | Option exercise | +2 | – | – | 36 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Mar 3, 2025 | Option exercise | +2 | – | – | 25 |
| Marvin L. White President and CEO, Director | Mar 3, 2025 | Option exercise | +6 | – | – | 55 |
| Daphne Taylor SVP, CFO | Mar 2, 2025 | Option exercise | +2 | – | – | 17 |
| Jeffrey G. Lamothe EVP, COO | Mar 2, 2025 | Option exercise | +3 | – | – | 34 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Mar 2, 2025 | Option exercise | +2 | – | – | 23 |
| Marvin L. White President and CEO, Director | Mar 2, 2025 | Option exercise | +8 | – | – | 49 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Aug 8, 2024 | Option exercise | +213 | – | – | 801 |
| Jeffrey G. Lamothe EVP, COO | Aug 8, 2024 | Option exercise | +42 | – | – | 894 |
| Jeffrey G. Lamothe EVP, COO | Aug 8, 2024 | Option exercise | +272 | – | – | 1,166 |
| Daphne Taylor SVP, CFO | Aug 8, 2024 | Option exercise | +158 | – | – | 576 |
| John Niederhuber Director | Jun 2, 2024 | Option exercise | +81 | – | – | 217 |
| Zsolt Harsanyi Director | Jun 2, 2024 | Option exercise | +81 | – | – | 280 |
| Grady Grant III Director | Jun 2, 2024 | Option exercise | +81 | – | – | 198 |
| Daniel Abdun-Nabi Director | Jun 2, 2024 | Option exercise | +81 | – | – | 277 |
| Barbara Lopez Kunz Director | Jun 2, 2024 | Option exercise | +81 | – | – | 198 |
| John Niederhuber Director | Jun 1, 2024 | Option exercise | +7 | – | – | 136 |
| Zsolt Harsanyi Director | Jun 1, 2024 | Option exercise | +7 | – | – | 199 |
| Grady Grant III Director | Jun 1, 2024 | Option exercise | +7 | – | – | 117 |
| Daniel Abdun-Nabi Director | Jun 1, 2024 | Option exercise | +7 | – | – | 196 |
| Barbara Lopez Kunz Director | Jun 1, 2024 | Option exercise | +7 | – | – | 117 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | May 31, 2024 | Option exercise | +42 | – | – | 588 |
| Daphne Taylor SVP, CFO | Mar 4, 2024 | Option exercise | +1,584 | – | – | 18,411 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Mar 3, 2024 | Option exercise | +3,667 | – | – | 24,042 |
| Jeffrey G. Lamothe EVP, COO | Mar 3, 2024 | Option exercise | +3,667 | – | – | 37,504 |
| Marvin L. White President and CEO, Director | Mar 3, 2024 | Option exercise | +9,584 | – | – | 67,430 |
| SoYoung Kwon SVP, GC, BD & Corp Affairs | Mar 2, 2024 | Option exercise | +3,667 | – | – | 20,375 |
| Daphne Taylor SVP, CFO | Mar 2, 2024 | Option exercise | +3,667 | – | – | 16,827 |
| Jeffrey G. Lamothe EVP, COO | Mar 2, 2024 | Option exercise | +5,500 | – | – | 33,837 |
| Marvin L. White President and CEO, Director | Mar 2, 2024 | Option exercise | +12,917 | – | – | 57,846 |
| Daphne Taylor SVP, CFO | Jan 29, 2024 | Option exercise | +792 | – | – | 13,160 |
| Jeffrey G. Lamothe EVP, COO | Jan 28, 2024 | Option exercise | +1,833 | – | – | 28,337 |
| Marvin L. White President and CEO, Director | Jan 28, 2024 | Option exercise | +4,792 | – | – | 44,929 |
| Zsolt Harsanyi Director | Aug 9, 2023 | Option exercise | +3,571 | – | – | 8,475 |
| Grady Grant III Director | Aug 9, 2023 | Option exercise | +3,571 | – | – | 4,880 |
| Barbara Lopez Kunz Director | Aug 9, 2023 | Option exercise | +3,571 | – | – | 4,880 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Aptevo Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 124,973 shares on Sep 4, 2026 over the last 90 days.
Congress trades
1 trade in Aptevo Therapeutics reported by 1 member of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Steve Cohen TN09 | Sold | Jun 24, 2019 | $470 | Jul 3, 2019 |
See a number that looks wrong?